Guizhou Bailing Group Pharmaceutical Co Ltd (002424) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.090x

Based on the latest financial reports, Guizhou Bailing Group Pharmaceutical Co Ltd (002424) has a cash flow conversion efficiency ratio of 0.090x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥294.76 Million ≈ $43.13 Million USD) by net assets (CN¥3.28 Billion ≈ $480.36 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Guizhou Bailing Group Pharmaceutical Co market cap and net worth for the company's overall valuation and market capitalisation.

Guizhou Bailing Group Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Guizhou Bailing Group Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Guizhou Bailing Group Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guizhou Bailing Group Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore Guizhou Bailing Group Pharmaceutical Co cash earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Douglas Dynamics Inc NYSE:PLOW	-0.082x
Orient Semiconductor Electronics Ltd TW:2329	0.023x
Cisen Pharmaceutical Co Ltd SHG:603367	0.049x
Zhejiang Ausun Pharmaceutical Co Ltd SHG:603229	0.051x
Sichuan Shudao Equipment & Technology Co Ltd SHE:300540	-0.073x
SpyGlass Pharma, Inc. NASDAQ:SGP	-0.064x
Railtel Corporation Of India Limited NSE:RAILTEL	-0.095x
Lintes Technology Co Ltd TW:6715	-0.004x

Annual Cash Flow Conversion Efficiency for Guizhou Bailing Group Pharmaceutical Co Ltd (2007–2025)

The table below shows the annual cash flow conversion efficiency of Guizhou Bailing Group Pharmaceutical Co Ltd from 2007 to 2025. View 002424 stock price and chart for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥3.17 Billion ≈ $464.57 Million	CN¥748.72 Million ≈ $109.56 Million	0.236x	+8263.87%
2024-12-31	CN¥3.20 Billion ≈ $468.14 Million	CN¥9.02 Million ≈ $1.32 Million	0.003x	-92.09%
2023-12-31	CN¥3.53 Billion ≈ $516.15 Million	CN¥125.77 Million ≈ $18.40 Million	0.036x	-71.62%
2022-12-31	CN¥4.00 Billion ≈ $584.87 Million	CN¥502.15 Million ≈ $73.48 Million	0.126x	+53.13%
2021-12-31	CN¥3.96 Billion ≈ $579.50 Million	CN¥324.92 Million ≈ $47.55 Million	0.082x	+38.77%
2020-12-31	CN¥3.92 Billion ≈ $573.66 Million	CN¥231.78 Million ≈ $33.92 Million	0.059x	-47.68%
2019-12-31	CN¥4.14 Billion ≈ $605.25 Million	CN¥467.41 Million ≈ $68.40 Million	0.113x	+381.70%
2018-12-31	CN¥3.92 Billion ≈ $574.31 Million	CN¥-157.45 Million ≈ $-23.04 Million	-0.040x	-274.11%
2017-12-31	CN¥3.47 Billion ≈ $507.36 Million	CN¥79.88 Million ≈ $11.69 Million	0.023x	-84.86%
2016-12-31	CN¥3.07 Billion ≈ $448.56 Million	CN¥466.62 Million ≈ $68.28 Million	0.152x	-1.24%
2015-12-31	CN¥2.68 Billion ≈ $392.31 Million	CN¥413.23 Million ≈ $60.47 Million	0.154x	-8.57%
2014-12-31	CN¥2.35 Billion ≈ $343.57 Million	CN¥395.83 Million ≈ $57.92 Million	0.169x	+153.01%
2013-12-31	CN¥2.13 Billion ≈ $311.30 Million	CN¥141.76 Million ≈ $20.74 Million	0.067x	+597.39%
2012-12-31	CN¥2.04 Billion ≈ $298.89 Million	CN¥19.52 Million ≈ $2.86 Million	0.010x	-90.82%
2011-12-31	CN¥1.94 Billion ≈ $283.94 Million	CN¥201.90 Million ≈ $29.54 Million	0.104x	+142.93%
2010-12-31	CN¥1.85 Billion ≈ $270.28 Million	CN¥-447.68 Million ≈ $-65.51 Million	-0.242x	-172.42%
2009-12-31	CN¥374.42 Million ≈ $54.79 Million	CN¥125.31 Million ≈ $18.34 Million	0.335x	+317.54%
2008-12-31	CN¥262.75 Million ≈ $38.45 Million	CN¥-40.42 Million ≈ $-5.92 Million	-0.154x	+64.59%
2007-12-31	CN¥182.68 Million ≈ $26.73 Million	CN¥-79.37 Million ≈ $-11.61 Million	-0.434x	--

About Guizhou Bailing Group Pharmaceutical Co Ltd

SHE:002424 China Drug Manufacturers - Specialty & Generic

Market Cap

$920.31 Million

CN¥6.29 Billion CNY

Market Cap Rank

#9327 Global

#2349 in China

Share Price

CN¥4.50

Change (1 day)

+0.90%

52-Week Range

CN¥4.09 - CN¥6.18

All Time High

CN¥28.52